Search - tctmd.com

Displaying 981 - 1000 of 1533

Sort: Relevancy | Date

News Daily News

El Injerto de Perfil Más bajo para TEVAR Confirma la Seguridad y Éxito del Dispositivo a 1 Año

L.A. McKeown

August 10, 2015

News Daily News

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

L.A. McKeown

August 05, 2015

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Industry News

Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent

August 03, 2015

News Daily News

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

Yael L. Maxwell

July 31, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

Yael L. Maxwell

July 29, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

Advertisement

El Injerto de Perfil Más bajo para TEVAR Confirma la Seguridad y Éxito del Dispositivo a 1 Año

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content